Vergoeding 2018-2022 voor ATC-subgroep N02CC : Selectieve serotonine-agonisten
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| N02CC01 Sumatriptan (Imigran ®) | 12.144.800 | 12.669.200 | 12.125.100 | 13.514.900 | 15.227.800 |
| N02CC02 Naratriptan (Naramig ®) | 171.820 | 164.620 | 148.990 | 133.330 | 140.150 |
| N02CC03 Zolmitriptan (Zomig zip ®) | 277.530 | 426.850 | 372.560 | 279.130 | 346.360 |
| N02CC04 Rizatriptan (Maxalt ®) | 1.633.200 | 1.558.000 | 1.581.100 | 1.252.600 | 1.543.200 |
| N02CC05 Almotriptan (Almogran ®) | 398.760 | 388.760 | 325.630 | 309.470 | 326.250 |
| N02CC06 Eletriptan (Relpax ®) | 1.920.000 | 1.885.600 | 1.630.200 | 1.579.400 | 1.790.200 |
| N02CC07 Frovatriptan (Fromirex ®) | 717.870 | 893.520 | 745.220 | 721.010 | 869.830 |
| Totaal | 17.263.980 | 17.986.550 | 16.928.800 | 17.789.840 | 20.243.790 |